Ali Chartan News Today

Achieved revenues in Q4 2023 of $291 million and full year 2023 of $1.0 billion Accelerating progress toward expanding pipeline via Phase 3 COVID-19-Influenza...

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance...

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th...

Novavaxs updated vaccine will be available at vaccination centers across TaiwanGAITHERSBURG, Md., Dec. 18, 2023 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines...

/CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the launch of Choose to...

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Health Canada...

Novavaxs updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming daysGAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- Novavax,...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M(TM) adjuvant,today announced that Nuvaxovid(TM) XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™...

New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plansJohn Trizzino appointed to new Chief...